No significant change of plasma β-endorphin levels of psoriasis patients after synchronous balneophototherapy

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 4, 2004, Pages 205-209

  Holló, Peter ^a,b   Bender, T ^c   Marschalko M ^a   Gonzalez, R ^a   Barna, I ^d   Horvath A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b TOMESA Synchronous Balneophotother   (Hungary)

^c Hosp Brother of St John of God ^*  (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

endorphin; Psoriasis; Synchronous balneophototherapy

Indexed keywords

BETA ENDORPHIN;

ADULT; ARTICLE; BALNEOTHERAPY; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOMODULATION; MALE; NEUROMODULATION; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIASIS; RADIOIMMUNOASSAY; SCORING SYSTEM; SKIN INFLAMMATION; SYMPTOMATOLOGY;

ADULT; BALNEOLOGY; BETA-ENDORPHIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOTHERAPY; PSORIASIS; RADIOIMMUNOASSAY;

EID: 4043052266     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00105.x     Document Type: Article

References (25)

1. Pincelli C, Fantini F, Giannetti A. Neuropeptides and skin inflammation. Dermatology 1993; 187: 153-158.
2. Wintzen M, Gilchrest BA. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 1996; 106: 3-10.
3. Blalock JE A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989; 69: 1-32.
4. Rogers SCF, Shuster S, Marks JM, Penny RJ, Thody AJ. The effects of photochemotherapy on endocrine secretion in patients with psoriasis. Acta Derm Venereol (Stockholm) 1980; 61: 350-352.
5. Slominski A, Wortsman J, Mazurkiewicz JE, et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993; 122: 658-666.
6. Nissen JB, Avrach VV, Hansen ES, Stengaard-Pedersen K, Kragballe K. Increased levels of enkephalin following natural sunlight (combined with salt water bathing at the Dead Sea) and ultraviolet A irradiation. Br J Dermatol 1998; 139: 1012-1019.
7. Bigliardi PL, Bigliardi-Qui M, Büchner S, Rufli T. Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 1998; 111: 297-301.
8. Bigliardi-Qui M, Bigliardi PL, Büchner S, Rufli T. Characterisation of mu-opiate receptor in human epidermis and keratinocytes. Ann N Y Acad Sci 1999; 885: 368-371.
9. Bigliardi-Qui M, Bigliardi PL, Eberle AE, Büchner S, Rufli T. Beta endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Invest Dermatol 2000; 114: 527-532.
10. Kauser S, Schallreuter KU, Thody AJ, Gummer C, Tobin DJ. Regulation of human epidermal melanocyte biology by beta-endorphin. J Invest Dermatol 2003; 120: 1073-1080.
11. Slominski A. Beta-endorphin/mu-opiate receptor system in the skin. J Invest Dermatol 2003; 120: xii-xiii.
12. Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol. 1994; 33: 356-360.
13. Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986; 14: 305-311.
14. Farber EM, Raychaudhuri SP. Is psoriasis a neuroimmunologic disease? Int J Dermatol 1999; 38: 12-15.
15. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997; 137: 843-850.
16. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
17. Schiffner R, Schiffner-Rohe J, Wölfl G, et al. Evaluation of a multicentre study of synchronous application of narrow-band ultraviolet B phototherapy (TL-1) and bathing in Dead Sea salt solution for psoriasis. Br J Dermatol 2000; 142: 740-747.
18. Gambichler T, Küster W, Kreuter A, et al. Balneophototherapy- combined treatment of psoriasis vulgaris and atopic dermatitis with salt water baths and artificial ultraviolet radiation. J Eur Acad Dermatol Venereol 2000; 14: 425-428.
19. Barna I, Koenig JI Effects of mediobasal hypothalamic lesion on immunoreactive ACTH/beta-endorphin levels in cerebrospinal fluid, in discrete brain regions, in plasma, and in pituitary of the rat. Brain Res 1992; 593: 69-76.
20. Wintzen M, Yaar M, Avila E, et al. Keratinocytes produce beta-endorphin and beta-lipotropic hormone after stimulation by UV, IL-1alfa, and phorbol esters. J Invest Dermatol 1995; 104: 641-648.
21. Gambichler T, Bader A, Vojvodic M, et al. Plasma levels of opioid peptides after sunbed exposures. Br J Dermatol 2002; 147: 1207-1211.
22. Levins PC, Carr DB, Fisher JE, et al. Plasma beta-endorphin and beta-lipotropin response to ultraviolet radiation. Lancet 1983; ii: 166.
23. Wintzen M, Ostijn DM, Polderman MC, le Cessie S, Burbach JP, Vermeer BJ. Total body exposure to ultraviolet radiation doesn't influence plasma levels of immunoreactive beta-endorphin in man. Photodermatol Photoimmunol Photomed 2001; 17: 256-260.
24. Wintzen M, de Winter S, Out-Luiting JJ, Van Duinen SG, Vermeer BJ. Presence of immunoreactive beta-endorphin in human skin. Exp Dermatol 2001; 10: 305-311.
25. Pezalla PD, Lis M, Seidah NG, Chretien M. Lipotropin, melanotropin and endorphin: in vivo catabolism and entry into cerebrospinal fluid. Can J Neurol Sci 1978; 5: 183-188.